These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33061905)

  • 1. Non-linear Relationship Between Plasma Amyloid-β 40 Level and Cognitive Decline in a Cognitively Normal Population.
    Gao F; Shang S; Chen C; Dang L; Gao L; Wei S; Wang J; Huo K; Deng M; Wang J; Qu Q
    Front Aging Neurosci; 2020; 12():557005. PubMed ID: 33061905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The plasma level of amyloid-β is associated with cognitive decline: a two years follow-up study in Xi'an rural areas].
    Li JY; Gao L; Wei S; Dang LJ; Shang SH; Chen C; Qu QM
    Zhonghua Nei Ke Za Zhi; 2019 Sep; 58(9):656-661. PubMed ID: 31461816
    [No Abstract]   [Full Text] [Related]  

  • 3. Ten-year change in plasma amyloid beta levels and late-life cognitive decline.
    Okereke OI; Xia W; Selkoe DJ; Grodstein F
    Arch Neurol; 2009 Oct; 66(10):1247-53. PubMed ID: 19822780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-linear Character of Plasma Amyloid Beta Over the Course of Cognitive Decline in Alzheimer's Continuum.
    Pan FF; Huang Q; Wang Y; Wang YF; Guan YH; Xie F; Guo QH
    Front Aging Neurosci; 2022; 14():832700. PubMed ID: 35401142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults.
    He L; de Souto Barreto P; Aggarwal G; Nguyen AD; Morley JE; Li Y; Bateman RJ; Vellas B;
    Alzheimers Res Ther; 2020 Oct; 12(1):128. PubMed ID: 33032662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults.
    Peng X; Xu Z; Mo X; Guo Q; Yin J; Xu M; Peng Z; Sun T; Zhou L; Peng X; Xu S; Yang W; Bao W; Shan Z; Li X; Liu L
    Diabetologia; 2020 May; 63(5):954-963. PubMed ID: 32034441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study.
    Wang J; Qiao F; Shang S; Li P; Chen C; Dang L; Jiang Y; Huo K; Deng M; Wang J; Qu Q
    J Alzheimers Dis; 2018; 64(1):61-69. PubMed ID: 29865072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Midlife Plasma Amyloid-β Levels With Cognitive Impairment in Late Life: The ARIC Neurocognitive Study.
    Sullivan KJ; Blackshear C; Simino J; Tin A; Walker KA; Sharrett AR; Younkin S; Gottesman RF; Mielke MM; Knopman D; Windham BG; Griswold ME; Mosley TH
    Neurology; 2021 Sep; 97(11):e1123-e1131. PubMed ID: 34349010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.
    Seppälä TT; Herukka SK; Hänninen T; Tervo S; Hallikainen M; Soininen H; Pirttilä T
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1123-7. PubMed ID: 20478847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects.
    Lue LF; Pai MC; Chen TF; Hu CJ; Huang LK; Lin WC; Wu CC; Jeng JS; Blennow K; Sabbagh MN; Yan SH; Wang PN; Yang SY; Hatsuta H; Morimoto S; Takeda A; Itoh Y; Liu J; Xie H; Chiu MJ
    Front Aging Neurosci; 2019; 11():222. PubMed ID: 31551751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies.
    van Steenoven I; van der Flier WM; Scheltens P; Teunissen CE; Lemstra AW
    Alzheimers Res Ther; 2019 Oct; 11(1):83. PubMed ID: 31601267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of Plasma Amyloid-β and Cognitive Decline in Cognitively Unimpaired Population.
    Wang J; Gao L; Liu J; Dang L; Wei S; Hu N; Gao Y; Peng W; Shang S; Huo K; Wang J; Qu Q
    Clin Interv Aging; 2022; 17():555-565. PubMed ID: 35480964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI).
    de Rojas I; Romero J; Rodríguez-Gomez O; Pesini P; Sanabria A; Pérez-Cordon A; Abdelnour C; Hernández I; Rosende-Roca M; Mauleón A; Vargas L; Alegret M; Espinosa A; Ortega G; Gil S; Guitart M; Gailhajanet A; Santos-Santos MA; Moreno-Grau S; Sotolongo-Grau O; Ruiz S; Montrreal L; Martín E; Pelejà E; Lomeña F; Campos F; Vivas A; Gómez-Chiari M; Tejero MA; Giménez J; Pérez-Grijalba V; Marquié GM; Monté-Rubio G; Valero S; Orellana A; Tárraga L; Sarasa M; Ruiz A; Boada M;
    Alzheimers Res Ther; 2018 Nov; 10(1):119. PubMed ID: 30497535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
    Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN
    J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma amyloid is associated with the rate of cognitive decline in cognitively normal elderly: the SCIENCe project.
    Verberk IMW; Hendriksen HMA; van Harten AC; Wesselman LMP; Verfaillie SCJ; van den Bosch KA; Slot RER; Prins ND; Scheltens P; Teunissen CE; Van der Flier WM
    Neurobiol Aging; 2020 May; 89():99-107. PubMed ID: 32081465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study.
    Pomara N; Bruno D; Plaska CR; Ramos-Cejudo J; Osorio RS; Pillai A; Imbimbo BP; Zetterberg H; Blennow K
    Transl Psychiatry; 2022 Jul; 12(1):301. PubMed ID: 35902554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study.
    Peters KE; Davis WA; Taddei K; Martins RN; Masters CL; Davis TM; Bruce DG
    J Alzheimers Dis; 2017; 56(3):1127-1133. PubMed ID: 28106562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.